— Product
CARICORT 1ML INJ
TRIAMCINOLONE 40MG
CARICORT 1ML INJ is an injection of triamcinolone acetonide 40 mg, a long-acting corticosteroid given by intramuscular, intra-articular or intralesional injection. It is used for inflammatory joint disease, bursitis and tendonitis, severe allergic conditions, and inflammatory skin lesions such as keloids and localised dermatoses.
01
Benefits
- The depot formulation provides sustained anti-inflammatory effect over weeks from a single injection.
- Intra-articular injection delivers concentrated relief to an inflamed joint with limited systemic exposure.
- Effective in bursitis, tendonitis and epicondylitis where localised inflammation is the problem.
- Intralesional injection flattens keloid and hypertrophic scars and clears localised inflammatory skin lesions.
- A useful option in severe allergic conditions where a sustained systemic effect is needed and adherence to oral steroid is uncertain.
02
Side effects
Not everyone gets these. Most are mild and settle as the course finishes.
Common
- Rise in blood glucose
- Flushing of the face
- Insomnia or restlessness
- Temporary increase in pain at the injection site in the first day or two
Less common
- Skin thinning, dimpling or loss of pigment at the injection site
- Mood disturbance or agitation
- Fluid retention and a rise in blood pressure
- Menstrual irregularity
Stop and get medical help if any of these occur
- Fever, spreading redness, swelling or increasing pain in an injected joint — this may be septic arthritis
- Severe abdominal pain, or black or tarry stools
- Marked confusion, agitation or psychotic symptoms
- Very high blood glucose with thirst, frequent urination and drowsiness
- Sudden inability to bear weight on an injected joint, or tendon rupture
03
Precautions
- For administration by a qualified healthcare professional only, using strict aseptic technique for joint injection.
- Contraindicated in systemic fungal infection, and absolutely contraindicated where there is infection in or near the joint or lesion to be injected.
- Never inject directly into a tendon — this risks rupture. Injection is around the tendon sheath, not into the tendon substance.
- Limit repeat intra-articular injections at any one joint, typically to no more than three or four a year; repeated injection damages cartilage.
- Raises blood glucose. Diabetic patients need closer monitoring and often a temporary increase in their usual therapy.
- Corticosteroids mask the signs of infection and impair the response to it.
- Repeated depot dosing suppresses the adrenal axis and can cause the full range of systemic steroid effects — this is not a harmless local treatment.
- Use with caution in uncontrolled hypertension, heart failure, peptic ulcer disease, osteoporosis, glaucoma and psychiatric illness. Live vaccines are contraindicated.